Skip to main content

OSU Medicine, Purdue Pharma announce research collaboration to fight opioid addiction

Purdue Pharma L.P. (“Purdue”) and the National Center for Wellness & Recovery (the “Center”) at Oklahoma State University today announced an innovative collaboration focused on accelerating solutions to the opioid addiction crisis.
Stethoscope
Opioid Epidemic Response

Fri, May 31, 2019

A $1.4 million award from the Center for Disease Control, awarded to the Oklahoma Department of Health and subcontracted to OSU Center for Health Sciences, will allow the Center for Wellness and Recovery to provide education on the use of prescription opioids, and treatment of opioid-use disorders in four of Oklahoma’s hardest hit communities: McAlester, Tahlequah, Duncan, and Ardmore.

OSU Center for Health SciencesCenter for Health SciencesOpioid Abuse
$200 Million to Establish Endowment for OSU Center for Wellness & Recovery

Tue, Mar 26, 2019

Attorney General Mike Hunter and Oklahoma State University leaders today announced an historic settlement with Purdue Pharma that will establish a nearly $200 million endowment at the Oklahoma State University’s Center for Wellness and Recovery, which will go toward treating the ongoing addiction epidemic nationwide.

Opioid AbuseGrantsHuman Health and WellnessCenter for Wellness & RecoveryHighlightedResearchCenter for Health Sciences

Back To Top
SVG directory not found.
MENUCLOSE